Katy Perry shakes off social media hate at triumphant opening Aus show. From a wardrobe emergency to an endearing Left Shark guest star, Katy Perry wins Aussie hearts at opening concert of sold ...

Jeuveau is a neuromodulator — a botulinum toxin A, just like Botox, Xeomin, Dysport, and Daxxify — that’s FDA-approved to treat the glabellar lines, aka your frown lines or “11s.” (It ...

It’ll be one fine day for George Clooney when he can go back to his roots. The actor, 64, isn’t thrilled about dyeing his hair brunette for his Broadway play “Good Night, and Good Luck ...

Salma Hayek spilled her beauty secrets to Vogue this week, including her hack for covering gray hair using mascara. Plus, her go-to skincare routine.

Hailing from South Korea, Letybo is the sixth and most recent neuromodulator approved by the FDA. Here, dermatologists unpack its benefits and key FYIs.

What to Consider Hydration. Smoothing and softening your hair texture requires moisturizing formulas and deep-conditioning treatments, explains Nunzio Saviano, a hairstylist and founder of his ...

We wish to give an overview over BT's mechanisms of action relevant for understanding its therapeutic use. Botulinum toxin structure. BT is produced by Clostridium botulinum and consists, of a complex ...

Botox remains one of the most popular aesthetic treatments in the UK. With an estimated 900,000 injections carried out annually in our country, we’re pretty taken by the stuff. But our desire for less ...

AUSTIN (KXAN) — Gov. Greg Abbott vetoed legislation which aimed to enhance Botox patient safety and transparency Monday, calling the measure “unnecessary and overly-burdensome” for business ...

Add articles to your saved list and come back to them any time. Speedy telehealth consultations granting patients access to Botox, lip fillers and other beauty treatments will become “unviable ...

A 59-year-old woman has gone viral after revealing her completely natural face—free of Botox—for the first time in years. She then faced backlash for sharing her decision to return to injections.